Abstract
The ability of levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone to interfere on biofilm produced by Pseudomonas aeruginosa, Haemophilus influenzae and Streptococcus pneumoniae isolated from patients with chronic obstructive pulmonary disease was evaluated. The effects of antibiotics were evaluated on formation of biofilm (at 1/2, 1/4 and 1/8 X MIC) and on preformed biofilm (at epithelial lining fluid peak concentrations) by means of a spectrophotometric method. Levofloxacin was the most active compound followed by ciprofloxacin, moxifloxacin and amoxicillin/clavulanic acid and ceftriaxone. Levofloxacin may contribute to clear the reservoir of pathogens involved in chronic obstructive pulmonary disease, thus leading to decreased occurrence of acute exacerbations.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amoxicillin-Potassium Clavulanate Combination / pharmacology*
-
Anti-Bacterial Agents / pharmacology*
-
Aza Compounds / pharmacology*
-
Biofilms / drug effects*
-
Biofilms / growth & development
-
Ceftriaxone / pharmacology*
-
Ciprofloxacin / pharmacology*
-
Dose-Response Relationship, Drug
-
Fluoroquinolones
-
Haemophilus influenzae / drug effects*
-
Haemophilus influenzae / growth & development
-
Haemophilus influenzae / isolation & purification
-
Humans
-
Levofloxacin*
-
Microbial Sensitivity Tests
-
Moxifloxacin
-
Ofloxacin / pharmacology*
-
Pseudomonas aeruginosa / drug effects*
-
Pseudomonas aeruginosa / growth & development
-
Pseudomonas aeruginosa / isolation & purification
-
Pulmonary Disease, Chronic Obstructive / microbiology*
-
Quinolines / pharmacology*
-
Spectrophotometry
-
Streptococcus pneumoniae / drug effects*
-
Streptococcus pneumoniae / growth & development
-
Streptococcus pneumoniae / isolation & purification
-
Time Factors
Substances
-
Anti-Bacterial Agents
-
Aza Compounds
-
Fluoroquinolones
-
Quinolines
-
Ciprofloxacin
-
Levofloxacin
-
Amoxicillin-Potassium Clavulanate Combination
-
Ceftriaxone
-
Ofloxacin
-
Moxifloxacin